Department of Cardiac Sciences, King Abdulaziz Medical City and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Cardiac Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland.
Crit Care. 2020 Dec 24;24(1):702. doi: 10.1186/s13054-020-03369-5.
COVID-19 has caused great devastation in the past year. Multi-organ point-of-care ultrasound (PoCUS) including lung ultrasound (LUS) and focused cardiac ultrasound (FoCUS) as a clinical adjunct has played a significant role in triaging, diagnosis and medical management of COVID-19 patients. The expert panel from 27 countries and 6 continents with considerable experience of direct application of PoCUS on COVID-19 patients presents evidence-based consensus using GRADE methodology for the quality of evidence and an expedited, modified-Delphi process for the strength of expert consensus. The use of ultrasound is suggested in many clinical situations related to respiratory, cardiovascular and thromboembolic aspects of COVID-19, comparing well with other imaging modalities. The limitations due to insufficient data are highlighted as opportunities for future research.
在过去的一年中，COVID-19 造成了巨大的破坏。包括肺部超声（LUS）和焦点心脏超声（FoCUS）在内的多器官即时护理超声（PoCUS）作为一种临床辅助手段，在 COVID-19 患者的分诊、诊断和医疗管理方面发挥了重要作用。来自 27 个国家和 6 个大洲的专家小组在直接应用 PoCUS 治疗 COVID-19 患者方面具有丰富的经验，他们使用 GRADE 方法评估证据质量，并采用加速、改良的 Delphi 程序评估专家共识的强度，提出了基于证据的共识。超声的应用在与 COVID-19 的呼吸、心血管和血栓栓塞方面相关的许多临床情况下都得到了建议，与其他成像方式相比具有优势。由于数据不足而导致的局限性被视为未来研究的机会。
